
Truist raised its Nvidia price target to $287 from $283 and maintained a Buy, while several other firms (Rosenblatt $325, Wolfe $275, Bernstein $300, William Blair, Stifel) reiterated Buy/Outperform ratings and raised or affirmed targets. Analysts cited rising inference demand, datacenter backlog details, evolving product 'tokenomics' and new Blackwell and Rubin products, with Rosenblatt projecting over $1 trillion combined revenue for 2025–2027 and others noting ~$1T revenue visibility for 2026–27, implying upside to consensus over the next 1–2 years.
Nvidia’s product cadence is creating a multi-year hardware upgrade cycle, but the real alpha sits in constrained nodes of the supply chain: HBM and advanced packaging capacity will monetize incremental GPU ASPs faster than card-level volumes. Expect pricing and gross-margin leverage to be asymmetric — initial order fills will carry full ASPs while follow-on replenishment and second-wave buyers face steeper ASP declines as foundry and OSAT capacity expands over 12–24 months. Competitive dynamics will increasingly be decided by scale economics inside hyperscalers and foundries. Hyperscalers with in-house accelerators can blunt Nvidia’s TAM growth by vertically integrating inference stacks; conversely, companies that accelerate procurement (short-cycle capex) will extract disproportionate bargaining power on pricing and lead times in the next 6–18 months. Key reversal risks are execution and demand composition: a meaningful slowdown in large-model training or a shift to model sparsity/quantization could compress incremental inference demand within a single fiscal year. Geopolitical export controls or a sudden inventory build at large cloud customers are immediate triggers that would snap the current optimism far faster than a structural compute deceleration over multiple years.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.70
Ticker Sentiment